MedTrace Logo

Study on Neuropsychiatric Behavior in Cadmium-exposed People

NCT06572566 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2026-04-21

No results posted yet for this study

Summary

This study hypothesized that excessive cadmium is related to clinical pain, depression, and cognitive impairment, and that related indicators will improve after cadmium is eliminated.

Conditions

  • Cadmium Exceeds the Standard

Interventions

OTHER

Non-invasive examination and assessment.

1\) Test the blood and urine components of all subjects to evaluate the damage to kidney function caused by excessive cadmium. 2) Conduct MRI examinations on all subjects to evaluate changes in brain functional connectivity, metabolism, and structure after excessive cadmium exposure. 3) Conduct bone density examinations on all subjects to evaluate changes in bone density after excessive cadmium exposure. (3) Clinical psychiatric assessment: All subjects will be assessed on their mental and psychological conditions such as pain, cognitive function, depression, anxiety, mania, sleep quality, and suicide risk.

Sponsors & Collaborators

  • Jianersheng (Zhuhai) Pharmaceutical Technology Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Fang Pei · Hunan Occupational Disease Prevention and Control Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-08
Primary Completion
2026-03-30
Completion
2026-03-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06572566 on ClinicalTrials.gov